Please use this identifier to cite or link to this item:
http://hdl.handle.net/1843/66470
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.creator | João Paulo Bonardi | pt_BR |
dc.creator | Rodrigo dos Santos Pereira | pt_BR |
dc.creator | Fernanda Brasil Daura Jorge Boos Lima | pt_BR |
dc.creator | Leonardo Perez Faverani | pt_BR |
dc.creator | Geraldo Luiz Griza | pt_BR |
dc.creator | Roberta Okamoto | pt_BR |
dc.creator | Eduardo Hochuli-Vieira | pt_BR |
dc.date.accessioned | 2024-03-25T18:48:45Z | - |
dc.date.available | 2024-03-25T18:48:45Z | - |
dc.date.issued | 2018-02 | - |
dc.citation.volume | 76 | pt_BR |
dc.citation.issue | 2 | pt_BR |
dc.citation.spage | 325 | pt_BR |
dc.citation.epage | 335 | pt_BR |
dc.identifier.doi | https://doi.org/10.1016/j.joms.2017.09.020 | pt_BR |
dc.identifier.issn | 02782391 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/1843/66470 | - |
dc.description.resumo | Purpose: The aim of this study was to compare ChronOS (β-tricalcium phosphate), Bio-Oss, and their addition to an autogenous bone graft in a 1:1 ratio in human maxillary sinus bone augmentation. Materials and methods: Thirty maxillary sinuses were divided in 5 groups: group 1 included 6 maxillary sinuses grafted with autogenous bone graft alone; group 2 included 6 maxillary sinuses grafted with ChronOS; group 3 included 6 maxillary sinuses grafted with ChronOS and autogenous bone graft in a 1:1 ratio; group 4 included 6 maxillary sinuses grafted with Bio-Oss; and group 5 included 6 maxillary sinuses grafted with Bio-Oss and autogenous bone graft in a 1:1 ratio. The number of samples for each group was determined by the statistical power test. Results: The median areas of new bone formation in groups 1, 2, 3, 4, and 5 were 121,917.0, 83,787.0, 99,295.0, 65,717.0, and 56,230.0 μm2, respectively. Statistically significant differences were found between groups 3 and 5, groups 1 and 4, and groups 1 and 5 (P < .05). The median areas of remaining biomaterial were 2,900.5, 5,291.0, 2,662.0, 56,258.5, and 64,753.5 μm2 in groups 1, 2, 3, 4 and 5, respectively. Statistically significant differences occurred between groups 1 and 5, groups 3 and 5, and groups 2 and 5 (P < .05). Areas of connective tissue were 67,829.0 ± 22,984.6 μm2 in group 1, 97,445.9 ± 18,983.3 μm2 in group 2, 88,256.0 ± 21,820.5 μm2 in group 3, 65,501.8 ± 6,297.6 in group 4, and 70,203.2 ± 13,421.3 μm2 in group 5. Conclusions: ChronOS combined with autogenous bone graft presented a behavior similar to that of autogenous bone graft alone. However, the groups treated with Bio-Oss showed immuno-labeling results indicating maturation of grafted bone. | pt_BR |
dc.language | eng | pt_BR |
dc.publisher | Universidade Federal de Minas Gerais | pt_BR |
dc.publisher.country | Brasil | pt_BR |
dc.publisher.department | FAO - DEPARTAMENTO DE CLÍNICA | pt_BR |
dc.publisher.initials | UFMG | pt_BR |
dc.relation.ispartof | Journal of oral and maxillofacial surgery | pt_BR |
dc.rights | Acesso Restrito | pt_BR |
dc.subject | periódico: Journal of oral and maxillofacial surgery acesso restrito assunto Bone Transplantation busca dia 21/02/2024 fao clínica Prospective and randomized evaluation of chronos and bio-oss in human maxillary sinuses: histomorphometric and immunohistochemical assignment for runx 2, vascular endothelial growth factor, and osteocalcin | pt_BR |
dc.subject.other | Bone transplantation | pt_BR |
dc.subject.other | Phosphates | pt_BR |
dc.subject.other | Bone and bones | pt_BR |
dc.subject.other | Maxillary sinus | pt_BR |
dc.title | Prospective and randomized evaluation of chronos and bio-oss in human maxillary sinuses: histomorphometric and immunohistochemical assignment for runx 2, vascular endothelial growth factor, and osteocalcin | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.url.externa | https://www.sciencedirect.com/science/article/pii/S0278239117312442?via%3Dihub | pt_BR |
Appears in Collections: | Artigo de Periódico |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.